Adamchak Mark 4
4 · Bionano Genomics, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Bionano Genomics (BNGO) P.A.O. Mark Adamchak Withholds 7 Shares
What Happened
- Mark Adamchak, Principal Accounting Officer of Bionano Genomics, reported that 7 shares of common stock were withheld by the company on June 3, 2026 to satisfy tax-withholding obligations related to RSUs that vested that day. The shares were valued at $1.30 each, totaling $9.
- This was a tax-withholding/cashless settlement of vested restricted stock units (not an open-market sale or purchase).
Key Details
- Transaction date and price: June 3, 2026 — 7 shares withheld at $1.30 per share (total $9).
- Transaction code: F (withholding to satisfy tax obligations).
- Footnote: The shares were withheld in connection with RSUs granted on June 3, 2024 and vesting on June 3, 2026.
- Shares owned after transaction: Not reported in the provided filing details.
- Filing timeliness: Report filed same day (no late filing indicated).
Context
- This is a routine tax-withholding event when RSUs vest; the company retained shares instead of issuing cash or selling shares on the open market. It does not signal a discretionary sale by the insider and typically has no direct implication about insider sentiment.
Insider Transaction Report
Form 4
Adamchak Mark
Principal Accounting Officer
Transactions
- Tax Payment
Common Stock
[F1]2026-06-03$1.30/sh−7$9→ 253 total
Footnotes (1)
- [F1]The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact|2026-06-03